Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-029 - NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases

      Presenter: Ernest Nadal

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-070 - High Incidence of Peridiagnosis Thromboembolic Events In Patients with BRAF Mutant Lung Cancer

      Presenter: Inmaculada Aparicio Salcedo

      • Abstract

      Loading...

  • +

    P1.12 - Management of Lung Cancer in the Era of COVID-19

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      P1.12-04 - The FLARE score and circulating neutrophils are associated with poor Covid-19 outcomes in patients with thoracic cancers

      Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)

    • 08:30 - 10:20
    • 8/08/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N/A
    • +

      PL03.12 - Progression Free Survival and Overall Survival in NADIM II Study

      Presenter: Mariano Provencio

      • Abstract

      Loading...

  • +

    OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?

    • 11:00 - 12:00
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • +

      OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)

      11:32 - 11:42  |  Presenter: Edouard Auclin

      • Abstract

      Loading...

  • +

    MA06 - Resectable and Unresectable Locally Advanced Lung Cancer

    • 12:15 - 13:15
    • 8/08/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Locally Advanced Non-small Cell Lung Cancer
    • +

      MA06.03 - Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial

      12:17 - 12:22  |  Presenter: Atocha Romero

      • Abstract

      Loading...

  • +

    OA13 - Evolving Epidemiology of Lung Cancer Beyond Tobacco

    • 10:45 - 11:45
    • 8/09/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Epidemiology
    • +

      OA13.04 - Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study

      10:57 - 11:07  |  Presenter: Miguel Garcia Pardo

      • Abstract

      Loading...